About Naveris. Naveris is a commercial stage, precision oncology company that is redefining the diagnosis and management of viral-induced cancers. Our proprietary Tumor Tissue Modified Viral (TTMV™) DNA biomarker has demonstrated best-in-class analytical and clinical performance in dozens of clinical studies, allowing for the potential of earlier detection of cancer in 100,000’s of patients annually. Our flagship test, NavDx, is used by over 1,20...
